Participating Companies

Acorn Energy (Nasdaq: ACFN)

Acorn Energy, Inc., makes conventional energy safer, cheaper and cleaner. Through its 2 subsidiaries in the US, one in Australia and one in Israel, it provides technology driven solutions for energy infrastructure asset management worldwide.

Americas Petrogas (CVE: BOE)

Americas Petrogas Inc. engages in the exploration, development, and production of oil and gas properties in Argentina. Strategic Partners are supermajor Exxon and major Apache. The company explores for conventional and unconventional oil and gas properties, including shale oil, shale gas and liquids, and tight sands. The company, through its subsidiary, is also involved in the exploration and development of the Bayovar Potash Brine Concession for phosphate, calcium sulphate, bromine, lithium, and magnesium chloride minerals covering an area of approx. 82,000 hectares and located in Peru.

Chronix Biomedical

Chronix Biomedical. Inc. is pioneering a unique approach to the detection of personal biomarkers for, monitoring and management of a broad range of cancers, neurologic diseases and other medical conditions. It has developed proprietary technology that measures and categorizes DNA sequences circulating in the blood that are associated with specific changes in disease and health status. Using advanced genome analysis methodology, proprietary data tools and disease-specific databases, Chronix has published its results on spongiform encephalopathies, multiple sclerosis, breast cancer, prostate cancer and multiple myeloma in several scientific journals. It is currently conducting studies in other cancers.

Inovio Pharmaceuticals (NYSE AMEX: INO)

Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV). The Company's electroporation delivery technology uses brief, controlled electrical pulses to increase cellular uptake of the vaccine. The Company's clinical programs include cervical dysplasia (therapeutic), avian influenza (preventive), prostate cancer (therapeutic), leukemia (therapeutic), hepatitis C virus (HCV) and HIV vaccines. It is advancing preclinical research and clinical development for a universal seasonal/pandemic influenza vaccine, as well as preclinical work for other products, including malaria and prostate cancer vaccines. As of December 31, 2011 it owned 16.1% interest in VGX Int'l.

Matrix Service Co. (Nasdaq: MTRX)

Matrix Service Company provides construction, and repair and maintenance services primarily to the energy and energy related industries in the United States and internationally. The company operates in two segments, Construction Services, and Repair and Maintenance Services.

OncoSec Medical, Inc. (OTC: ONSC)

OncoSec Medical Incorporated, a recent spinoff from Inovio, is pioneering an immunotherapy method for skin cancer that is hugely effective in prolonging life compared to other older methods. OncoSec is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers. ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy and other treatment alternatives.

Titan International (NYSE: TWI)

Titan International, Inc. (Titan), through its subsidiaries, is engaged in the manufacturing of wheels and tires. It operates in three segments: agricultural, earthmoving/construction and consumer. Its customers include AGCO Corporation, CNH Global N.V., Deere & Company and Kubota Corporation.